Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) CEO Martine A. Rothblatt sold 8,000 shares of the business’s stock in a transaction on Friday, March 24th. The shares were sold at an average price of $217.95, for a total transaction of $1,743,600.00. Following the sale, the chief executive officer now directly owns 130 shares of the […]
Advisor Resource Council cut its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 16.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,293 shares of the biotechnology company’s stock after selling 258 shares during the quarter. Advisor […]
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) have earned an average rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell rating and eight have given a buy rating to the company. The average twelve-month price objective […]
Harbor Capital Advisors Inc. decreased its holdings in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 26.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 313 shares of the biotechnology company’s stock after selling 114 shares during the period. Harbor Capital […]
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) CEO Martine A. Rothblatt sold 8,000 shares of the company’s stock in a transaction dated Wednesday, March 22nd. The shares were sold at an average price of $216.01, for a total transaction of $1,728,080.00. Following the completion of the transaction, the chief executive officer now owns 130 shares […]